A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
Göran Tornling, Charlotte Edenius, John D Pauling, Christopher P Denton, Anna Olsson, Jan Kowalski, Andrea Murray, Marina Anderson, Smita Bhat, Francesco Del Galdo, Frances Hall, Mariusz Korkosz, Dorota Krasowska, Jacek Olas, Vanessa Smith, Jacob M van Laar, Madelon C Vonk, Anna Wojteczek, Ariane L Herrick
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's'. Together they form a unique fingerprint.